BRPI0919319A2 - soro do leite e funcao do timo - Google Patents

soro do leite e funcao do timo

Info

Publication number
BRPI0919319A2
BRPI0919319A2 BRPI0919319A BRPI0919319A BRPI0919319A2 BR PI0919319 A2 BRPI0919319 A2 BR PI0919319A2 BR PI0919319 A BRPI0919319 A BR PI0919319A BR PI0919319 A BRPI0919319 A BR PI0919319A BR PI0919319 A2 BRPI0919319 A2 BR PI0919319A2
Authority
BR
Brazil
Prior art keywords
whey
thymus function
thymus
function
Prior art date
Application number
BRPI0919319A
Other languages
English (en)
Inventor
Cecile Loi
Christine Charrueau
Christophe Moinard
Denis Breuille
Eric Delpierre
Karine Vidal
Luc Cynober
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0919319A2 publication Critical patent/BRPI0919319A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
BRPI0919319A 2008-09-19 2009-09-14 soro do leite e funcao do timo BRPI0919319A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08105395A EP2165713B1 (en) 2008-09-19 2008-09-19 Whey and thymus function
PCT/EP2009/061876 WO2010031744A1 (en) 2008-09-19 2009-09-14 Whey and thymus function

Publications (1)

Publication Number Publication Date
BRPI0919319A2 true BRPI0919319A2 (pt) 2015-12-29

Family

ID=40342721

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919319A BRPI0919319A2 (pt) 2008-09-19 2009-09-14 soro do leite e funcao do timo

Country Status (14)

Country Link
US (1) US8409592B2 (pt)
EP (2) EP2165713B1 (pt)
JP (1) JP2012502945A (pt)
CN (1) CN102186494A (pt)
AU (1) AU2009294704A1 (pt)
BR (1) BRPI0919319A2 (pt)
CA (1) CA2737771A1 (pt)
DK (1) DK2337573T3 (pt)
ES (1) ES2443965T3 (pt)
MX (1) MX2011002980A (pt)
PT (1) PT2337573E (pt)
RU (1) RU2011115185A (pt)
WO (1) WO2010031744A1 (pt)
ZA (1) ZA201102911B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5377202B2 (ja) * 2009-09-29 2013-12-25 テルモ株式会社 栄養強化用食品素材
JP5377203B2 (ja) * 2009-09-30 2013-12-25 テルモ株式会社 術後補助食
WO2012057636A1 (en) * 2010-10-27 2012-05-03 Fonterra Corporate Research And Development Limited Modulation of th1 and th2 immune response by lactic acid whey
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
EP3668499A1 (en) 2017-08-14 2020-06-24 Axcella Health Inc. Amino acid compositions for the treatment of liver disease
WO2019246225A1 (en) 2018-06-20 2019-12-26 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
US10933097B1 (en) 2020-03-05 2021-03-02 King Saud University Method of treating a bacterial infection using colostrum

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1295557A1 (ru) * 1984-06-05 1989-03-30 Кубанский государственный университет Способ получени пептидной фракции кумыса,обладающей иммуностимулирующим действием
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
FI892006A7 (fi) * 1988-04-29 1989-10-30 Phil Gold Laktalbumiini ruoan lisäaineena
US5576351A (en) * 1989-12-29 1996-11-19 Mcgaw, Inc. Use of arginine as an immunostimulator
FR2711529B1 (fr) 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
DE69523791T2 (de) * 1994-10-14 2002-09-05 Morinaga Milk Industry Co. Ltd., Tokio/Tokyo Peptid-mischung und produkte davon
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
EP1065947B1 (en) * 1998-03-31 2003-04-23 Societe Des Produits Nestle S.A. Use of a composition for providing glutamine
DE69930746T2 (de) * 1998-06-10 2007-03-15 Crum, Albert B. Vorbeugender und therapeutischer nahrungsmittelzusatz zur schaffung/erhaltung einer die gesundheit schützenden darmmikroflora und zur stärkung des immunsystems
DE19856789A1 (de) * 1998-12-09 2000-06-15 Nutricia Nv Thymuswachstumsstimulierende Säuglingsnahrung
ATE303077T1 (de) * 1999-04-29 2005-09-15 Nestle Sa Süssmolkeprotein enthaltende säuglingsnahrung
US6833350B2 (en) * 2000-02-04 2004-12-21 Nestec S.A. Method for maintaining or improving the synthesis of mucins
PT1385498E (pt) * 2001-04-18 2007-12-14 Prometic Biosciences Inc Ácidos gordos como factores de sobrevivência e activação de neutrófilos
ATE372689T1 (de) * 2001-07-18 2007-09-15 Dsm Ip Assets Bv Verfahren zur hydrolyse von milcheiweissen
DK1638418T3 (da) 2003-06-23 2012-09-17 Nestec Sa Aminosyretilsætning til et sundt mikrobiota-økosystem
US20080108548A1 (en) * 2004-11-12 2008-05-08 N.V. Nutricia Food Composition For Rapidly Attenuating Inflammatory Responses
DK1848446T3 (da) * 2005-02-09 2010-02-15 Vifor Int Ag anvendelse af jern(III)-kompleksforbindelser
CN100542430C (zh) * 2007-05-21 2009-09-23 北京东方兴企食品工业技术有限公司 一种含有益生菌的营养蛋白粉

Also Published As

Publication number Publication date
WO2010031744A1 (en) 2010-03-25
EP2337573A1 (en) 2011-06-29
CN102186494A (zh) 2011-09-14
MX2011002980A (es) 2011-05-10
DK2337573T3 (da) 2014-01-20
CA2737771A1 (en) 2010-03-25
US20120039944A1 (en) 2012-02-16
RU2011115185A (ru) 2012-10-27
ZA201102911B (en) 2012-09-26
EP2165713A1 (en) 2010-03-24
EP2165713B1 (en) 2012-11-14
ES2443965T3 (es) 2014-02-21
AU2009294704A1 (en) 2010-03-25
PT2337573E (pt) 2014-01-09
US8409592B2 (en) 2013-04-02
EP2337573B1 (en) 2013-12-25
JP2012502945A (ja) 2012-02-02

Similar Documents

Publication Publication Date Title
NO2021036I1 (no) Ofatumumab
NO2020020I1 (no) Polatuzumab vedotin
BRPI0912431A2 (pt) Combinações de substâncias ativas sinergísticas
BRPI0806899A2 (pt) Implante parcialmente bioabsorvível
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0914789A2 (pt) efeitos sinérgicos
DK2023664T3 (da) Aktiv støjudligning i høreapparater
BRPI0914996A2 (pt) enxerto pespontado implantável
EP2256192A4 (en) CATALASE WITH TEMPERATURE TOLERANCE
FR2912051B1 (fr) Implant trapezo-metacarpien
BRPI0821652A2 (pt) tratamento de biocombustíveis
BRPI0812228A2 (pt) Combinações de substâncias ativas fungicidas
BRPI0919319A2 (pt) soro do leite e funcao do timo
BRPI0812208A2 (pt) Combinações de substância ativas fungicidas
BRPI0911199A2 (pt) microbiocidas
BRPI0908722A2 (pt) reformadora ativa
FI20095184L (fi) Houkutin
BRPI0813781A2 (pt) microbiocidas
HRP20170146T1 (hr) Pufa-prekriveni implantati
UA18383S (uk) Кришка-сидіння для унітазу
DE112009003312A5 (de) Implantat
BRPI0810812A2 (pt) leite glicado e suas utilizações
EP2340650A4 (en) HEARING AID
FI20085952L (fi) Kyllästys
FR2940520B1 (fr) Structure semiconductrice

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2368 DE 24-05-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.